tiprankstipranks
Trending News
More News >
Maze Therapeutics, Inc. (MAZE)
:MAZE
US Market
Advertisement

Maze Therapeutics, Inc. (MAZE) Technical Analysis

Compare
58 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
0Bearish
Maze Therapeutics, Inc.’s (MAZE) Moving Averages Convergence Divergence (MACD) indicator is 1.29, suggesting Maze Therapeutics, Inc. is a Buy.
Maze Therapeutics, Inc.’s (MAZE) 20-Day exponential moving average is 30.76, while Maze Therapeutics, Inc.’s (MAZE) share price is $38, making it a Buy.
Maze Therapeutics, Inc.’s (MAZE) 50-Day exponential moving average is 27.32, while Maze Therapeutics, Inc.’s (MAZE) share price is $38, making it a Buy.

Maze Therapeutics, Inc. (MAZE) Pivot Points

Nov 30, 2025, 12:56 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.71
28.85
30.35
31.49
32.99
34.13
35.63
Fibonacci
28.85
29.86
30.48
31.49
32.50
33.12
34.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Maze Therapeutics, Inc. (MAZE) Moving Averages

Nov 30, 2025, 12:56 PM
Period
Simple
Exponential
MA5
31.94Buy
31.92Buy
MA10
31.38Buy
31.55Buy
MA20
31.15Buy
30.76Buy
MA50
27.53Buy
27.32Buy
MA100
21.03Buy
22.90Buy
MA200
Maze Therapeutics, Inc.’s (MAZE) 10-Day exponential moving average is 31.55, while Maze Therapeutics, Inc.’s (MAZE) share price is $38, making it a Buy.
Maze Therapeutics, Inc.’s (MAZE) 100-Day exponential moving average is 22.90, while Maze Therapeutics, Inc.’s (MAZE) share price is $38, making it a Buy.
Maze Therapeutics, Inc.’s (MAZE) stock price is $38 and Maze Therapeutics, Inc.’s (MAZE) 50-day simple moving average is 27.53, creating a Buy signal.
Maze Therapeutics, Inc.’s (MAZE) stock price is $38 and Maze Therapeutics, Inc.’s (MAZE) 100-day simple moving average is 21.03, creating a Buy signal.

Maze Therapeutics, Inc. (MAZE) Technical Indicators

Nov 30, 2025, 12:56 PM
Name
Value
Implied Action
RSI (14)
60.57
Neutral
STOCH (9,6)
78.16
Neutral
STOCHRSI (14)
73.00
Neutral
MACD (12,26)
1.29
Buy
ADX (14)
37.10
Neutral
Williams %R
-24.00
Buy
CCI (14)
81.83
Neutral
ATR (14)
2.21
-
Ultimate Oscillator
61.07
Neutral
ROC
4.94
Buy
Maze Therapeutics, Inc.’s (MAZE) Relative Strength Index (RSI) is 60.57, creating a Neutral signal.
Maze Therapeutics, Inc.’s (MAZE) Trend Strength Indicator (ADX) is 37.10, creating a Neutral signal.
Maze Therapeutics, Inc.’s (MAZE) Commodity Channel Index (CCI) is 81.83, creating a Neutral signal.
Maze Therapeutics, Inc.’s (MAZE) Price Rate of Change (ROC) is 4.94, creating a Buy signal.

FAQ

Is MAZE a Buy, Hold, or Sell?
Based on MAZE’s technical indicators, MAZE is a Strong Buy.
    What is MAZE’s RSI (14)?
    MAZE’s RSI (14) is 60.57, which suggests MAZE is a Neutral.
      What is MAZE’s MACD?
      MAZE’s MACD is 1.29, which suggests MAZE is a Buy.
        What is MAZE’s 5-day moving average?
        MAZE’s 5-day moving average is 31.94, which suggests MAZE is a Buy.
          What is MAZE’s 20-day moving average?
          MAZE 20-day moving average is 31.15, which suggests MAZE is a Buy.
            What is MAZE’s 50-day moving average?
            MAZE’s 50-day moving average is 27.53, which suggests MAZE is a Buy.
              What is MAZE’s 200-day moving average?
              Currently, no data Available
              What is MAZE’s Williams % R (14)?
              MAZE’s Williams % R (14) is -24.00, which suggests MAZE is a Buy.
                What is MAZE’s CCI (14)?
                MAZE’s CCI (14) is 81.83, which suggests MAZE is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis